DEG C57BL/6J PFC air (nondrinkers) vs air (drinkers) FDR < 0.01_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J PFC air (nondrinkers) vs air (drinkers) FDR < 0.01 (gene symbol)_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J PFC CIE (drinkers) vs air (nondrinkers) FDR < 0.01_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J PFC CIE (nondrinkers) vs air (drinkers) FDR < 0.01_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J PFC CIE vs air (nondrinkers) FDR < 0.01 (gene symbol)_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J PFC CIE (drinkers) vs air (nondrinkers) FDR < 0.01_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J PFC CIE (nondrinkers) vs air (drinkers) FDR < 0.01 (gene symbol)_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J NAc CIE vs air (drinkers) FDR < 0.01_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J NAc CIE (drinkers) vs air (nondrinkers) FDR < 0.01_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J NAc CIE (nondrinkers) vs air (drinkers) FDR < 0.01_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J NAc CIE vs air (drinkers) FDR < 0.01 (gene symbol)_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J NAc CIE (drinkers) vs air (nondrinkers) FDR < 0.01 (gene symbol)_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J HPC CIE vs air (drinkers) FDR < 0.01_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J HPC CIE vs air (drinkers) FDR < 0.01 (gene symbol)_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J HPC CIE (drinkers) vs air (nondrinkers) FDR < 0.01 (gene symbol)_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J CeA CIE vs air (drinkers) FDR < 0.01_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J CeA CIE vs air (drinkers) FDR < 0.01 (gene symbol)_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J CeA CIE (drinkers) vs air (nondrinkers) FDR < 0.01 (gene symbol)_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J BNST CIE vs air (drinkers) FDR < 0.01_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J BNST CIE (drinkers) vs air (nondrinkers) FDR < 0.01_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J BNST CIE vs air (drinkers) FDR < 0.01 (gene symbol)_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG C57BL/6J BNST CIE (drinkers) vs air (nondrinkers) FDR < 0.01 (gene symbol)_qvalue
Description:
Adult male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 10 weeks of age. Mice were kept under a 12-hour light/dark cycle and given free access to water and standard rodent chow (Harland, Teklad, Madison, WI). Studies were designed to determine genomic responses and interactions between two different ethanol exposure models: intermittent cycles of ethanol vapor exposure in inhalation chambers (CIE), and oral consumption of 15% (v/v) ethanol in a limited access (2 h/session) paradigm. Mice were divided into 4 treatment groups (n = 12/group): the “CIE Drinking” group received inhaled ethanol in the vapor chambers followed by 2-bottle choice ethanol drinking in between vapor exposure cycles; the “Air Drinking” group received only air in the vapor chambers, but had 2-bottle choice ethanol drinking between CIE cycles; the “CIE NonDrinking” group received inhaled ethanol in the vapor chambers but only water access in between CIE cycles; and the “Air NonDrinking” group remained ethanol naïve with air exposure in vapor chambers and only water consumption between CIE cycles. Following a 2-week acclimation period, mice in the CIE Drinking and Air Drinking groups underwent 6-weeks of 2-bottle choice drinking to establish baseline drinking levels. The 2-hr limited access session to ethanol (15 v/v) vs. water started 30 min before lights off. Ethanol and water intake for each individual mouse was measured daily. Following 6-weeks of baseline drinking, mice were placed in Plexiglass inhalation chambers (60x36x60 cm) 16 hours/day for 4 days. Ethanol was volatilized with an air stone submerged in 95% ethanol. Vapor chamber ethanol concentrations were monitored daily and air flow was adjusted to ethanol concentrations within 10–13 mg/l air. This ethanol vapor concentration has been shown to yield stable blood ethanol concentrations (175–225 mg/dL) in C57BL/6J mice [25]. Before each vapor chamber session, intoxication was initiated in the CIE group by administration of 1.6 g/kg ethanol and 1 mmol/kg pyrazole intraperitoneally (i.p.) at a volume of 0.02 ml/g body weight. Pyrazole is an alcohol dehydrogenase inhibitor used to stabilize blood ethanol concentrations. All mice received the same number and timing of pyrazole injections prior to final removal from the inhalation chambers with control mice receiving saline and pyrazole (i.p.), also at a volume of 0.02 ml/g body weight, prior to being placed into control vapor chambers. Control vapor chambers delivered only air without ethanol vapor. After 4 days in the inhalation chambers, mice underwent a 72-hour period of total abstinence from ethanol. Following the abstinence period, mice in the CIE Drinking and Air Drinking groups were given 2-bottle choice drinking for 2 hours per day for 5 days. A total of 4 cycles of CIE-abstinence-drinking were performed. After the end of the 4th cycle mice were sacrificed on the 5th drinking day before receiving ethanol/water access on that day at the time they received 2-bottle choice drinking all previous drinking days (Fig 1). Affymetrix GeneChip® Mouse Genome 430, type 2 arrays were analyzed with The R Project for Statistical Computing (http://www.r-project.org/). Statistical analysis to identify significantly regulated genes was performed using the limma package for R. False discovery rates equal to or less than 0.01 were considered significant.
Authors:
Maren L Smith, Marcelo F Lopez, Aaron R Wolen, Howard C Becker, Michael F Miles
DEG effect of treatment (CIE vs Air) in brains of C57BL/6J and DBA/2J mice (p < 0.01)_pvalue
Description:
Male C57BL/6J and DBA/2J mice (10 weeks old upon arrival) were purchased from the Jackson Laboratory and assigned to either the air control or CIE group. Mice were allowed to self-administer alcohol (15% v/v vs. water) for 2 h a day (5 days a week) 6 weeks prior to treatment in order to establish baseline consumption. Access to 15% alcohol versus water started 30 min prior to the start of the dark cycle. Following establishment of baseline drinking, two male mice representative of each strain were separated into two groups to be exposed to either weekly cycles of CIE exposure (CIE group) or air control (AIR group) exposure. There was no difference in baseline consumption or preference within strain prior to assignment to AIR or CIE treatment groups (Supplemental Fig. 1). As expected, there was a significant difference in alcohol consumption and preference between strains at baseline (B6 > D2, p < 0.01. Mice assigned to the CIE treatment group were exposed to alcohol vapor for 16 h a day followed by 8 h of withdrawal for 4 days. Following the fourth vapor exposure, mice were given a 72-h abstinence period before resuming ethanol intake in the home cage for 5 days. Mice in the AIR control treatment group were similarly treated but exposed only to air in the inhalation chambers. This pattern of CIE or air control exposure followed by 5 days of ethanol self-administration was repeated for four cycles. A fifth cycle of CIE (or air) exposure followed the fourth ethanol intake evaluation period, and brain tissue was collected 72 h after the last cycle ended. Poly-A enriched mRNA was sequenced on two platforms, ABI SOLID 550XL Wildfire (65 samples) and Ion Proton (39 samples). Differential gene expression was determined using the glm function in R where gene expression (Y) is dependent on treatment, strain, region, and treatment interactions with strain and region: Y ∼ Treatment + Strain + Region + Treatment*Strain + Treatment*Region. Treatment was coded as 0 for AIR and 1 for CIE, 0 for B6 and 1 for D2. Regions were collapsed into three groups based on PCA clustering and coded as 0 for hippocampus (CA1 and CA3 regions), 1 for cortex (Prl, ILC, and VCX), and 2 for the remaining subcortical and limbic and mesolimbic tissue (VTA, NAc, NAs, DMS, CeA, and BST).
Authors:
Megan K Mulligan, Khyobeni Mozhui, Ashutosh K Pandey, Maren L Smith, Suzhen Gong, Jesse Ingels, Michael F Miles, Marcelo F Lopez, Lu Lu, Robert W Williams
DEG effect of treatment (CIE vs Air) in brains of C57BL/6J and DBA/2J mice (p < 0.01)_qvalue
Description:
Male C57BL/6J and DBA/2J mice (10 weeks old upon arrival) were purchased from the Jackson Laboratory and assigned to either the air control or CIE group. Mice were allowed to self-administer alcohol (15% v/v vs. water) for 2 h a day (5 days a week) 6 weeks prior to treatment in order to establish baseline consumption. Access to 15% alcohol versus water started 30 min prior to the start of the dark cycle. Following establishment of baseline drinking, two male mice representative of each strain were separated into two groups to be exposed to either weekly cycles of CIE exposure (CIE group) or air control (AIR group) exposure. There was no difference in baseline consumption or preference within strain prior to assignment to AIR or CIE treatment groups (Supplemental Fig. 1). As expected, there was a significant difference in alcohol consumption and preference between strains at baseline (B6 > D2, p < 0.01. Mice assigned to the CIE treatment group were exposed to alcohol vapor for 16 h a day followed by 8 h of withdrawal for 4 days. Following the fourth vapor exposure, mice were given a 72-h abstinence period before resuming ethanol intake in the home cage for 5 days. Mice in the AIR control treatment group were similarly treated but exposed only to air in the inhalation chambers. This pattern of CIE or air control exposure followed by 5 days of ethanol self-administration was repeated for four cycles. A fifth cycle of CIE (or air) exposure followed the fourth ethanol intake evaluation period, and brain tissue was collected 72 h after the last cycle ended. Poly-A enriched mRNA was sequenced on two platforms, ABI SOLID 550XL Wildfire (65 samples) and Ion Proton (39 samples). Differential gene expression was determined using the glm function in R where gene expression (Y) is dependent on treatment, strain, region, and treatment interactions with strain and region: Y ∼ Treatment + Strain + Region + Treatment*Strain + Treatment*Region. Treatment was coded as 0 for AIR and 1 for CIE, 0 for B6 and 1 for D2. Regions were collapsed into three groups based on PCA clustering and coded as 0 for hippocampus (CA1 and CA3 regions), 1 for cortex (Prl, ILC, and VCX), and 2 for the remaining subcortical and limbic and mesolimbic tissue (VTA, NAc, NAs, DMS, CeA, and BST).
Authors:
Megan K Mulligan, Khyobeni Mozhui, Ashutosh K Pandey, Maren L Smith, Suzhen Gong, Jesse Ingels, Michael F Miles, Marcelo F Lopez, Lu Lu, Robert W Williams
DEG effect of treatment (CIE vs Air) x region interaction C57BL/6J and DBA/2J brains (p < 0.01)_pvalue
Description:
Male C57BL/6J and DBA/2J mice (10 weeks old upon arrival) were purchased from the Jackson Laboratory and assigned to either the air control or CIE group. Mice were allowed to self-administer alcohol (15% v/v vs. water) for 2 h a day (5 days a week) 6 weeks prior to treatment in order to establish baseline consumption. Access to 15% alcohol versus water started 30 min prior to the start of the dark cycle. Following establishment of baseline drinking, two male mice representative of each strain were separated into two groups to be exposed to either weekly cycles of CIE exposure (CIE group) or air control (AIR group) exposure. There was no difference in baseline consumption or preference within strain prior to assignment to AIR or CIE treatment groups (Supplemental Fig. 1). As expected, there was a significant difference in alcohol consumption and preference between strains at baseline (B6 > D2, p < 0.01. Mice assigned to the CIE treatment group were exposed to alcohol vapor for 16 h a day followed by 8 h of withdrawal for 4 days. Following the fourth vapor exposure, mice were given a 72-h abstinence period before resuming ethanol intake in the home cage for 5 days. Mice in the AIR control treatment group were similarly treated but exposed only to air in the inhalation chambers. This pattern of CIE or air control exposure followed by 5 days of ethanol self-administration was repeated for four cycles. A fifth cycle of CIE (or air) exposure followed the fourth ethanol intake evaluation period, and brain tissue was collected 72 h after the last cycle ended. Poly-A enriched mRNA was sequenced on two platforms, ABI SOLID 550XL Wildfire (65 samples) and Ion Proton (39 samples). Differential gene expression was determined using the glm function in R where gene expression (Y) is dependent on treatment, strain, region, and treatment interactions with strain and region: Y ∼ Treatment + Strain + Region + Treatment*Strain + Treatment*Region. Treatment was coded as 0 for AIR and 1 for CIE, 0 for B6 and 1 for D2. Regions were collapsed into three groups based on PCA clustering and coded as 0 for hippocampus (CA1 and CA3 regions), 1 for cortex (Prl, ILC, and VCX), and 2 for the remaining subcortical and limbic and mesolimbic tissue (VTA, NAc, NAs, DMS, CeA, and BST).
Authors:
Megan K Mulligan, Khyobeni Mozhui, Ashutosh K Pandey, Maren L Smith, Suzhen Gong, Jesse Ingels, Michael F Miles, Marcelo F Lopez, Lu Lu, Robert W Williams
Add Selected GeneSets to Project(s)
Warning: You are not signed in. Adding these genesets to a project will create a guest account for you.
Guest accounts are temporary, and will be removed within 24 hours of creation. Guest accounts can be registered as full accounts, but you cannot associate a guest account with an existing account.
If you already have an account, you should sign into that account before proceeding.